Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 8505636.
- Also identified by PMC identifier 1015002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Striatal dopamine D1 receptors were investigated in 11 patients with Parkinson's disease (PD), five patients with striatonigral degeneration (SND) and six age-matched controls by positron emission tomography and carbon-11 labelled SCH23390. The SND patients showed mean 12%, 21%, and 31% declines in the ratios of radioactivity in the caudate, anterior putamen, and posterior putamen compared with that in the occipital cortex. These ratios were not significantly altered in the PD patients. The results may explain the different therapeutic responses to levadopa between SND and PD patients, and this technique might prove useful for their differentiation.
Medical subject headings
- Brain
- Brain Diseases
- Corpus Striatum
- Nerve Degeneration
- Parkinson Disease
- Receptors, Dopamine D1
- Tomography, Emission-Computed